Novuson Overview

  • Founded
  • 2014

Founded
  • Status
  • Private

  • Employees
  • 5

Employees
  • Latest Deal Type
  • Crowdfunding

  • Latest Deal Amount
  • $116K

  • Investors
  • 7

Novuson General Information

Description

Developer of therapeutic ultrasound (DTU) technology designed to offer coagulation and hemostatic control in surgical and trauma procedures. The company's technology delivers devices that use focused ultrasound energy for enhanced and robust hemostasis, cauterization and ablation, enabling clinicians to perform surgeries efficiently and to rapidly control bleeding associated with traumatic injuries.

Contact Information

Website
www.novuson.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Primary Office
  • 11824 North Creek Parkway North
  • Suite 103
  • Bothell, WA 98011
  • United States
+1 (425) 000-0000

Novuson Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Novuson Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Equity Crowdfunding 30-Jun-2022 $116K 00.000 000.00 Completed Product Development
2. Later Stage VC (Series A) 12-Nov-2020 00.000 00.000 000.00 Completed Product Development
1. Grant 01-Jan-2016 $2.97M Completed Product Development
To view Novuson’s complete valuation and funding history, request access »

Novuson Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 00,000,000 00.000000 00.00 00.00 00 00.00 00.000
To view Novuson’s complete cap table history, request access »

Novuson Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of therapeutic ultrasound (DTU) technology designed to offer coagulation and hemostatic control in surgical an
Therapeutic Devices
Bothell, WA
5 As of 2023
00.000
00.00 0000-00-00
000000000000 00.000

000000

cididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud
00000000 0000000
Waltham, MA
000 As of 0000
00000
0.00 0000-00-00
000000&0 00000

000000

iqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut
00000000 0000000
Waltham, MA
000 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Novuson Competitors (11)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Corindus Vascular Robotics Formerly VC-backed Waltham, MA 000 00000 000000&0 00000
000000000 00000000 Formerly VC-backed Waltham, MA 000 00000 000000000 00000
00 00000000 Formerly VC-backed Toronto, Canada 00 00.00 000000&0 00.00
000000000 Venture Capital-Backed Toronto, Canada 000 00000 000000 - 000 00000
00 0000000 0000000 Corporate Backed or Acquired Peabody, MA 000 00000 000000&0 00000
You’re viewing 5 of 11 competitors. Get the full list »

Novuson Patents

Novuson Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3684241-A4 Therapeutic ultrasound apparatus and method Pending 18-Sep-2017 0000000000000
EP-3684241-A1 Therapeutic ultrasound apparatus and method Pending 18-Sep-2017 0000000000000
JP-2022084941-A Therapeutic ultrasound apparatus and method Pending 18-Sep-2017 0000000000000
US-20190083818-A1 Therapeutic ultrasound apparatus and method Active 18-Sep-2017 0000000000000
US-10925628-B2 Tissue engagement apparatus for theapeutic ultrasound apparatus and method Active 18-Sep-2017 A61B17/320092
To view Novuson’s complete patent history, request access »

Novuson Executive Team (7)

Name Title Board Seat Contact Info
Stuart Mitchell Ph.D Co-Founder, Chief Science Officer, Chairman, President, Chief Executive Officer & Board Member
Jean Maixner Executive Vice President of Operations and Finance
Juan Asensio MD Chief Medical Officer & Advisor of Surgical and Trauma Surgery Applications
Derek Khorsand Chief Medical Officer
You’re viewing 4 of 7 executive team members. Get the full list »

Novuson Board Members (6)

Name Representing Role Since
Carla Corkern Self Board Member 000 0000
Sam Liao Self Board Member 000 0000
You’re viewing 2 of 6 board members. Get the full list »

Novuson Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Novuson Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Hoya Group Corporation Minority 000 0000 000000 0
Keiretsu Capital Venture Capital Minority 000 0000 000000 0
Keiretsu Forum Venture Capital Minority 000 0000 000000 0
Newton Fund Corporation Minority 000 0000 000000 0
The Washington Medical Technology Angel Network Angel Group 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »